Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000670058 | SCV000794871 | uncertain significance | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2017-10-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002515117 | SCV003442502 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-02-03 | criteria provided, single submitter | clinical testing | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 461 of the MKS1 protein (p.Tyr461Cys). This variant is present in population databases (rs730882120, gnomAD 0.007%). This missense change has been observed in individual(s) with MKS1-related conditions (PMID: 24608809). ClinVar contains an entry for this variant (Variation ID: 183011). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MKS1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
OMIM | RCV000161134 | SCV000211852 | pathogenic | Bardet-Biedl syndrome 13 | 2014-01-01 | no assertion criteria provided | literature only |